Yalamanchi Naveen 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 15, 2022
Insider Transaction Report
Form 4
Yalamanchi Naveen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+47,745→ 47,745 totalExercise: $10.77Exp: 2032-06-13→ Common Stock (47,745 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.